Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

24.81p
   
  • Change Today:
      0.11p
  • 52 Week High: 107.61
  • 52 Week Low: 18.41
  • Currency: UK Pounds
  • Shares Issued: 350.89m
  • Volume: 400
  • Market Cap: 87.06m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim 13.64 (16.00) (6.76)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 n/a (8.91) (7.05)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (17.58) (15.42)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.54)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (14.48)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 27.01 (28.08) (12.62)p n/a n/a n/a n/a 0.0%
31-Dec-23 32.10 (21.83) (8.18)p n/a n/a n/a n/a 0.0%
31-Dec-24 41.07 (14.25) (4.36)p n/a n/a n/a n/a 0.0%

Copyright © 2023 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

CREO Market Data

Currency UK Pounds
Share Price 24.81p
Change Today 0.11p
% Change 0.46 %
52 Week High 107.61
52 Week Low 18.41
Volume 400
Shares Issued 350.89m
Market Cap 87.06m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.06% above the market average18.06% above the market average18.06% above the market average18.06% above the market average18.06% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Price Trend
96.33% below the market average96.33% below the market average96.33% below the market average96.33% below the market average96.33% below the market average
94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average94.87% below the sector average
Income Not Available
Growth
49.73% above the market average49.73% above the market average49.73% above the market average49.73% above the market average49.73% above the market average
72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average72.22% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 31-Mar-2023

Time Volume / Share Price
08:01 400 @ 25.00p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page